Počet záznamov: 1
heparín s nízkou molekulovou hmotnosťou
SYS d006495 LBL 00000cx--j2200000---45-- 005 20240119201016.7 100 $a 19920325asloy0103----ba0 152 $b mesh 250 $a heparín s nízkou molekulovou hmotnosťou $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 94; was ENOXAPARIN 1992-93, was HEPARIN, LOW MOLECULAR WEIGHT 1988-91; HEPARIN, LOW MOLECULAR WEIGHT was see ENOXAPARIN 1992-93; LOW-MOLECULAR-WEIGHT HEPARIN was LOW MOLECULAR WEIGHT HEPARIN 1988-93 $8 eng 300 1-
$a Heparin (1966-1987) $8 eng 330 1-
$a Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. $8 eng 450 $a LMWH $5 e $8 eng 450 $a Low-Molecular-Weight Heparin $5 e $8 eng 450 $a LMWH $5 e $8 slo 450 $a heparín nízkomolekulový $5 e $8 slo 550 $3 sllk_un_auth*d000925 $Y Anticoagulants $5 P $a antikoagulanciá 550 $3 sllk_un_auth*d005343 $Y Fibrinolytic Agents $5 P $a fibrinolytiká 686 $a D09.698.373.400.300 750 $a Heparin, Low-Molecular-Weight $8 eng 801 -0
$a US $b DNLM $c 19920325 801 -2
$a SK $b BA006 $c 20010702 801 -2
$a SK $b BA006 $c 20141003 820 $a /antag = probably HEPARIN ANTAGONISTS $8 eng 980 $x M
Počet záznamov: 1